MoneyWorks4Me

FDC - Quaterly Results

07 Feb 2024 Evaluate
The company witnessed a 11.22% growth in the revenue at Rs. 4522.15 millions for the quarter ended December 2023 as compared to Rs. 4066.06 millions during the year-ago period.Net profit for the quarter ended December 2023 increased significantly by 98.77% to Rs. 783.76 millions from Rs. 394.31 millions.Operating profit for the quarter ended December 2023 rose to 1072.32 millions as compared to 652.83 millions of corresponding quarter ended December 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 4522.15 4066.06 11.22 14619.53 13458.35 8.63 17770.32 15189.65 16.99
Other Income 253.31 187.63 35.01 825.00 667.93 23.52 539.12 787.34 -31.53
PBIDT 1072.32 652.83 64.26 3631.17 2444.61 48.54 3084.87 3255.80 -5.25
Interest 9.67 11.84 -18.33 30.56 28.91 5.71 40.39 30.48 32.51
PBDT 1062.65 640.99 65.78 3600.61 2415.70 49.05 3044.48 3225.32 -5.61
Depreciation 99.33 98.12 1.23 293.34 290.67 0.92 387.58 370.81 4.52
PBT 963.32 542.87 77.45 3307.27 2125.03 55.63 2656.90 2854.51 -6.92
TAX 179.56 148.56 20.87 717.59 487.77 47.12 647.25 658.15 -1.66
Deferred Tax -24.44 32.56 -175.06 -6.60 -54.23 -87.83 -42.75 -21.85 95.65
PAT 783.76 394.31 98.77 2589.68 1637.26 58.17 2009.65 2196.36 -8.50
Equity 162.81 165.91 -1.87 165.91 165.91 0.00 165.91 168.81 -1.72
PBIDTM(%) 23.71 16.06 47.69 24.84 18.16 36.74 17.36 21.43 -19.01
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..